We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sun Pharma Freezes Generic Eloxatin Sales

Law360 (February 11, 2011, 1:23 PM EST) -- Sun Pharmaceutical Industries Inc. has agreed to temporarily halt its sales of oxaliplatin, the active ingredient in Sanofi-Aventis US LLC’s colon cancer drug Eloxatin, as the parties decide how to proceed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.